Clinical Trial Update: An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors [EARLY_Phase 1]

View source ↗

Summary

A Mayo Clinic-sponsored early-phase 1 trial is evaluating 68Ga-DOTATATE PET/CT as a diagnostic tool for pediatric metastatic neuroendocrine tumors, including ga…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ganglioneuroblastoma
• Ganglioneuroma
• Neuroblastoma

Drugs mentioned

• 68Ga-DOTATATE (Gallium-68 DOTATATE)

Snippet

Sponsor: Mayo Clinic | Conditions: Ganglioneuroblastoma, Ganglioneuroma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING